| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/16/1997 | CA2182851A1 Method for treating substance abuse withdrawal |
| 02/15/1997 | CA2183208A1 Antidepressant 1-arylalkyl-4-(alkoxypyridinyl)-or 4-(alkoxypyrimidinyl) piperazine derivatives |
| 02/15/1997 | CA2183052A1 Use of acyl-substituted aminopyrans |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005139A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/13/1997 | WO1997005137A1 Heterocyclic compounds, their preparation and use |
| 02/13/1997 | WO1997005111A1 N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 02/13/1997 | WO1997005109A1 Heterocyclic compounds, their preparation and use |
| 02/13/1997 | WO1997005102A1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 02/13/1997 | WO1997004806A1 Remedy for neurological disorders |
| 02/13/1997 | WO1997004780A2 Pain-alleviating drug composition and method for alleviating pain |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004777A1 Use off unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
| 02/13/1997 | WO1997004760A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2224293A1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757716A1 Dna encoding bradykinin b 1? receptor |
| 02/12/1997 | EP0757687A1 Tricyclic derivatives as 5ht 2c? and 5ht 2b? antagonists |
| 02/12/1997 | EP0757686A1 Benzofuran derivatives as d 4? receptor antagonists |
| 02/12/1997 | EP0757685A1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 02/12/1997 | EP0757681A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 02/12/1997 | EP0757677A1 Benzocycloalkylazolethione derivatives |
| 02/12/1997 | EP0757674A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/12/1997 | EP0717991A4 Neurotropic agent and process for producing it |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/12/1997 | CN1142831A Novel 2-substituted indane-2-mercaploacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142825A Neuroprotective chroman compounds |
| 02/12/1997 | CN1142824A 3-substituted 1-arylindole compounds |
| 02/12/1997 | CN1142823A 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and analagonists |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142768A Use of PLA2 inhibitors as treatment for Alzheimer's disease |
| 02/12/1997 | CN1142498A (Thiophen-2-yl-)-piperidin or tetrahydropyridin azabicyclocarboxamides |
| 02/12/1997 | CN1142494A New Piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds, process for preparation thereof and pharmaceutical compositions containing them |
| 02/12/1997 | CN1034016C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 02/11/1997 | US5602257 Reacting piperidone aminal with nicotinic acid derivative to form aminal nicotinoyl piperidone salt; forming anabaseine salt |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602179 Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid with antagonistic activity towards cholecystokinin and a method for their preparation |
| 02/11/1997 | US5602176 Phenyl carbamate |
| 02/11/1997 | US5602169 Useful in reducing neuronal damage during ischemic stroke |
| 02/11/1997 | US5602163 Selective agonists of 5-hydroxytryptamine receptors; useful in treatment of migraine headaches |
| 02/11/1997 | US5602162 Imidazole, triazole and tetrazole derivatives |
| 02/11/1997 | US5602152 Benzoxepines |
| 02/11/1997 | US5602144 Thienopyridones |
| 02/11/1997 | US5602138 Neurokinin a antagonists; treating asthma |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602131 EburnanE analogues |
| 02/11/1997 | US5602103 Cerebral function-ameliorating agent |
| 02/11/1997 | US5602099 δ opioid receptor antagonists |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601842 Analgesics; contains a non-moisture sensitive matrixing agent |
| 02/11/1997 | US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 02/11/1997 | US5601838 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia |
| 02/11/1997 | US5601829 Pharmaceutical composition of activity in the treatment of cognitive and/or neuroimmune dysfunctions |
| 02/06/1997 | WO1997003987A1 Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 02/06/1997 | WO1997003984A1 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/06/1997 | WO1997003983A1 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt |
| 02/06/1997 | WO1997003982A1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 02/06/1997 | WO1997003979A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
| 02/06/1997 | WO1997003978A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003678A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | WO1997003673A1 Sustained-release formulation of d-threo-methylphenidate |
| 02/06/1997 | WO1997003670A1 Paroxetine controlled release compositions |
| 02/06/1997 | WO1997003665A1 Treatment of attention-deficit/hyperactivity disorder |
| 02/06/1997 | WO1997003662A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | WO1996031475A3 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227410A1 Treatment of attention-deficit/hyperactivity disorder |
| 02/06/1997 | CA2227208A1 Pharmaceutical composition of l-dopa ethyl ester |
| 02/06/1997 | CA2227034A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/06/1997 | CA2223646A1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 02/06/1997 | CA2223644A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
| 02/05/1997 | EP0756869A2 Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756602A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 02/05/1997 | EP0756596A1 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
| 02/05/1997 | EP0708778B1 Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 02/05/1997 | EP0663911B1 Benzopyranones, method of preparing them and their use |
| 02/05/1997 | EP0502038B1 Imidazoquinoxaline compounds, their preparation and use |
| 02/05/1997 | CN1142226A Novel heterocyclic compounds |
| 02/05/1997 | CN1142183A A method of treating neurogenic inflammation |
| 02/05/1997 | CN1141921A Chromone derivative |